Proteome Sciences (PRM)

 

PRM Share PerformanceMore

52 week high6.0000 28/11/16
52 week low2.6100 18/10/17
52 week change -2.1200 (-36.87%)
4 week volume4,983,763 28/10/17

Media for (PRM)

Presenter: Christopher Pearce
29/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

RNS Number: 1697W Proteome Sciences PLC 10 November 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Proteome S...

Director Deals - Proteome Sciences PLC (PRM)

Martin Diggle, Non Executive Director, bought 20,000 shares in the company on the 6th November 2017 at a price of 3.17p....

Director/PDMR Shareholding

RNS Number: 9351V Proteome Sciences PLC 08 November 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Director/PDMR Shareholding T he Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 6 November 2017, it purchased 20,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares")...

Director Deals - Proteome Sciences PLC (PRM)

Martin Diggle, Non Executive Director, bought 184,460 shares in the company on the 25th October 2017 at a price of 3.18p. T...

Holding(s) in Company

RNS Number: 8458U Proteome Sciences PLC 27 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: PROTEOME...

Director/PDMR Shareholding

RNS Number: 8464U Proteome Sciences PLC 27 October 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Director/PDMR Shareholding T he Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 24 October 2017 and 25 October 2017, it purchased 75,000 and 109,460 ordinary shares of 1p each, respectively, in the cap...

Director/PDMR Shareholding

RNS Number: 3433U Proteome Sciences PLC 23 October 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Director/PDMR Shareholding T he Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 18 and 19 October 2017 it purchased 256,520 and 193,100 ordinary shares of 1p each, respectively, in the capital of the Com...

Holding(s) in Company

RNS Number: 3432U Proteome Sciences PLC 23 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: PROTEOME ...

Fundamental DataMore

EPS-0.96
Dividend yield0 %

Latest discussion posts More

  • Wow!

    According to My Portfolio, my investment in PRM is now worth #97,500.which works out at #3.25 per share. I better sell quickly before they notice the mistake. John
    22-Nov-2017
    John of Groats
  • Re: Martin Diggle had better be on the m...

    G5 - I was aware that Diggle is investing for a fund, BUT all my comments still apply IF PRM can rehabilitate itself - lets hope some good news isnt too far off for PRM - its ...
    31-Oct-2017
    Andy Reilly
  • Re: Martin Diggle had better be on the money...

    Andy, it is not a personal holding but an investment for 2 funds under his management group.
    29-Oct-2017
    Gailes5

Users' HoldingsMore

Users who hold Proteome Sciences also hold..
LLOYDS GRP.22%
GLAXOSMITHKLINE14%
BARCLAYS14%
BP13%
ID:ISIN:GB00BDFB6Q6912%

Codes & Symbols

ISINGB0003104196
SymbolsPRM, LSE:PRM, PRM.L, PRM:LN, LON:PRM, XLON:PRM

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account